Dr Reddy's Inks Licensing Pact with Eli Lilly for Covid-19 Treatment Drug

This partnership comes at a critical juncture in the fight against the pandemic in India, and adds to the company's existing range of COVID-19 therapeutics covering the full spectrum from mild to moderate and severe conditions of the disease, and a vaccine, Dr Reddy's noted.

from Top Business News- News18.com